AVITA Medical, Inc. (RCEL) Cash from Investing Activities (2019 - 2025)

AVITA Medical (RCEL) has reported Cash from Investing Activities for 7 consecutive years, with $11000.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Cash from Investing Activities fell 99.55% year-over-year to $11000.0; the trailing twelve-month figure through Dec 2025 stood at $12.5 million (down 66.67% YoY), and the FY2025 full-year result was $12.5 million, down 66.67% from the prior year.
• Cash from Investing Activities rose to $11000.0 in Q4 2025 per RCEL's latest filing, from -$5.3 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $56.6 million in Q4 2022 and bottomed at -$57.3 million in Q4 2023.
• Historically, Cash from Investing Activities has averaged $2.0 million across 5 years, with a median of $7.0 million in 2025.
• The sharpest annual moves came in 2021 and 2023: Cash from Investing Activities tumbled 16853.38% in 2021, then surged 183.12% in 2023.
• Over 5 years, Cash from Investing Activities stood at -$50.2 million in 2021, then jumped by 212.81% to $56.6 million in 2022, then slumped by 201.23% to -$57.3 million in 2023, then soared by 104.31% to $2.5 million in 2024, then sank by 99.55% to $11000.0 in 2025.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered $11000.0, -$5.3 million, and $7.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.